Latest Articles
'Left in Limbo- Donegal women forced abroad for endometriosis care - Donegal Live - Big News Network
'Left in Limbo- Donegal women forced abroad for endometriosis care - Donegal Live Big News Network
Published: March 29, 2025, 12:47 a.m.
Dr Lan on the Efficacy of Cadonilimab Plus Lenvatinib in Advanced Endometrial Cancer - OncLive
Dr Lan on the Efficacy of Cadonilimab Plus Lenvatinib in Advanced Endometrial Cancer OncLive
Published: March 28, 2025, 10:08 p.m.
Dr Mirza on Long-Term Response Data for Dostarlimab Plus Chemo in Advanced Endometrial Cancer - OncLive
Dr Mirza on Long-Term Response Data for Dostarlimab Plus Chemo in Advanced Endometrial Cancer OncLive
Published: March 26, 2025, 10:21 p.m.
'Left in Limbo’: Donegal women forced abroad for endometriosis care - Ireland Live
'Left in Limbo’: Donegal women forced abroad for endometriosis care Ireland Live
Published: March 23, 2025, 4:38 p.m.
'Left in Limbo’: Donegal women forced abroad for endometriosis care - Donegal Live
'Left in Limbo’: Donegal women forced abroad for endometriosis care Donegal Live
Published: March 23, 2025, 4 p.m.
Trips taking kids harmed by Chernobyl to Nottingham forced to end - Yahoo News UK
Trips taking kids harmed by Chernobyl to Nottingham forced to end Yahoo News UK
Published: March 20, 2025, 6:58 p.m.
Endometrial Ablation Market Size to Hit USD 2.15 Bn by 2034 - Precedence Research
Endometrial Ablation Market Size to Hit USD 2.15 Bn by 2034 Precedence Research
Published: March 20, 2025, 1:41 p.m.
All layers of North West health service need to be adequately resourced - MacLochlainn - Ocean FM
All layers of North West health service need to be adequately resourced - MacLochlainn Ocean FM
Published: March 20, 2025, 9:40 a.m.
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - The Malaysian Reserve
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy The Malaysian …
Published: March 19, 2025, 10:53 p.m.
Canada Approves KEYTRUDA For Advanced Endometrial Cancer - Evrim Ağacı
Canada Approves KEYTRUDA For Advanced Endometrial Cancer Evrim Ağacı
Published: March 19, 2025, 2:55 p.m.
Link copied to clipboard!